Thyme Care names Brad Diephuis CEO as Robin Shah becomes executive chairman

The July 15 announcement outlines leadership changes effective immediately and on Sept. 1, 2026, as the oncology company says it now reaches 10.5 million Americans and manages $6 billion of oncology spend.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.